The future of new natural product drugs, facing critical situation

Published: 2014-10-22 14:28:29

Updated: 2014-10-22 14:57:38

Despite the government’s development policy of new natural product drugs, negative market recognition towards new natural product drugs has continuously spread. Natural product drugs, such as ‘Stillen’, ‘Joins’, ‘Shinbaro’, ‘Layla’ and ‘Motilitone’, are getting negatively criticized to the public.

‘Stillen’, in progress with a redemption lawsuit against National Health Insurance Corporation, i...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.